Dynavax Technologies Corp. (DVAX)
15.38
+0.02
(+0.10%)
USD |
NASDAQ |
Dec 30, 13:14
Dynavax Technologies Shareholders Equity (Quarterly): 534.14M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 51.85B |
| Agios Pharmaceuticals, Inc. | 1.284B |
| Hyperion DeFi, Inc. | 70.76M |
| Edgewise Therapeutics, Inc. | 558.65M |
| Moderna, Inc. | 9.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 946.51M |
| Total Liabilities (Quarterly) | 412.37M |
| Debt to Equity Ratio | 0.5415 |
| Current Ratio | 7.622 |
| Net Debt Paydown Yield | -0.58% |